Russia deepening localization in domestic pharma market

At least 90% of drugs from the list of vital medicines in Russia will be of domestic origin already by the end of 2025, according to latest predictions by some senior officials of the Russian Ministry of Health, reports The Pharma Letter’s local correspondent.

Currently, over 800 generic items and more than 5,000 trade named drugs that are available in the Russian market are positioned as “domestic drugs” in Russia. In May 2024, the Ministry reported that 80% of them are produced within the territory of the Russian Federation.

Still, this is just the beginning, while as part of state plans is to create conditions for deepening of the level of localization in the domestic pharmaceutical market. For this purpose, last summer the Russian government changed the rules for forming the list of vital drugs, providing a priority to Russian drugs or those whose production is localized within the territory of the country.